PubMed:33407777 / 685-901
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 47 | 119-127 | Species | denotes | patients | Tax:9606 |
| 48 | 133-182 | Disease | denotes | COVID-induced Acute Respiratory Distress Syndrome | MESH:D012128 |
| 49 | 184-188 | Disease | denotes | ARDS | MESH:D012128 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T2 | 153-173 | Phenotype | denotes | Respiratory Distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 0-216 | Sentence | denotes | A double-blind, randomized, controlled, trial to evaluate the efficacy and safety of MSC intravenous administration in patients with COVID-induced Acute Respiratory Distress Syndrome (ARDS) compared to a control arm. |